Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hong Kong Launches Expedited Drug Registration Process & Becomes ICH Observer

Executive Summary

Hong Kong is taking incremental steps to move towards a system where it can evaluate and approve new drugs more quickly and efficiently on its own. The moves include preparations for a new Hong Kong Centre for Medical Products Regulation.

You may also be interested in...

Qualifying Digital Biomarkers ‘Much Easier Now’ Thanks To EMA Efforts

The European Medicines Agency has been on a steep learning curve with its qualification of a digitally-measured outcome for use in Duchenne muscular dystrophy trials, smoothing the way for other developers entering the digital biomarker space.

EU Aims To Foster Innovation Through Streamlined Uptake Of Clinical Trial Methodologies

Regulators in the EU are to publish a roadmap next year on existing, ongoing and planned guidance activities on novel clinical trial methodologies.

EMA Considers Product Development Stage For Complying With ICH Guide On Bioanalytical Method Validation

The European Medicines Agency has drafted a plan to address specific issues that drug companies may face when it comes to complying with the International Council for Harmonisation’s M10 guideline. 


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts